Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > May 26, 2020
Daily News
May 26, 2020
- TB Drug Deltyba Approved in Russia: Otsuka
May 26, 2020
- Tanabe Mitsubishi Gets Tenelia OK in Thailand
May 26, 2020
- Novartis Launches AMD Drug Beovu in Japan
May 26, 2020
- Japan’s First Humalog Biosimilar to Join NHI Price List on May 27
May 26, 2020
- Daiichi Sankyo’s Enhertu Hits Japan Market for Breast Cancer
May 26, 2020
- Final Report from Govt’s All-Generation Social Security Council to Be Delayed until Year-End
May 26, 2020
- Simon Lee to Lead ViiV Japan from June
May 26, 2020
- Discontinued HIV Med Nelfinavir Hits Limelight as Potential COVID-19 Treatment
May 26, 2020
- Generic/Biosimilar Society Calls on MHLW to Ensure Stable API Supply
May 26, 2020
- Sawai Ponders Possible Delay in Rollout of 4 Generic Brands After June Listing
May 26, 2020
- Takeda’s NSCLC Med Alunbrig Nabs Frontline Nod in US
May 26, 2020
Japan’s pharmaceutical industry is undergoing a structural shift in its workforce, with the role of sales reps shrinking while production…
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…